Abstract:Objective. Polycystic ovary syndrome (PCOS) is one of the prevalent gynecological endocrine disorders encountered in clinical practice. Women diagnosed with PCOS demonstrate increased ovarian responsiveness, rendering them more prone to ovarian hyperstimulation syndrome (OHSS) during controlled ovarian stimulation (COS) procedures. The current study aimed at investigating whether CCL25/CCR9 plays a role in the pathological process of high ovarian response (HOR) during COS procedures. Design. Single‐center retrospective cohort study. Patients. A total of 200 PCOS patients who received a fixed regimen of gonadotropin‐releasing hormone (GnRH) antagonist were enrolled in this study. The cohort comprised 118 patients exhibiting HOR and 82 patients demonstrating a normal ovarian response (NOR). Results. The age and body mass index (BMI) variances across the two groups did not differ significantly. Similarly, the two groups observed no statistically significant differences in the baseline levels of luteinizing hormone (LH), progesterone (P), estradiol (E 2 ), basal prolactin (PRL), and testosterone (T). Compared to the NOR group, HOR patients exhibit markedly elevated levels of anti‐Müllerian hormone (AMH), antral follicle count (AFC), basal follicle‐stimulating hormone (FSH), and HOMA‐IR (all p < 0.05). Conversely, no statistically significant differences were observed between the two groups with respect to COS parameters, encompassing initial gonadotropin (Gn) dose, stimulation duration, and total Gn dose. During COS, the number of oocytes with diameter ≥14 mm, the levels of E 2 on the HCG day, and the number of retrieved oocytes were significantly higher in the HOR group than in the NOR group (all p < 0.001). Additionally, the levels of CCL25/CCR9, matrix metalloproteinases (MMPs), tissue inhibitor of metalloproteinases (TIMPs), TNF‐α, and IL‐6 were significantly higher in the FF of the HOR group than in the NOR group (all p < 0. 001), while the variance in IL‐1β levels between the two cohorts did not reach statistical significance. The relevance analysis results indicated that the levels of CCL25/CCR9 in the FF of the HOR group are positively correlated with the number of retrieved oocytes and oocytes with diameters ≥14 mm during COS, AMH levels, and AFC. Concurrently, the CCL25 levels in the FF of the HOR group were positively correlated with HOMA‐IR. Multivariable linear regression analysis revealed that the elevated AFC and HOMA‐IR independently increase the CCL25 levels. Conclusion. The CCL25/CCR9 levels in FF are positively correlated with the clinical indicators of HOR, suggesting that CCL25/CCR9 may play a role in the pathogenesis of HOR in patients with PCOS.

Premature response to luteinizing hormone of granulosa cells from women with polycystic ovary syndrome

Ovarian Leukocyte Distribution and Cytokine/chemokine Mrna Expression in Follicular Fluid Cells in Women with Polycystic Ovary Syndrome.

160.Ovarian Leukocytes and Cytokines in Polycystic Ovary Syndrome

Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome

Poor Ovarian Response To Gonadotropin Stimulation Is Associated With Low Expression Of Follicle-Stimulating Hormone Receptor In Granulosa Cells

Gene Expression in Granulosa Cells From Small Antral Follicles From Women With or Without Polycystic Ovaries

A Molecular Mechanism Underlying Ovarian Dysfunction of Polycystic Ovary Syndrome: Hyperandrogenism Induces Epigenetic Alterations in the Granulosa Cells

Profiles for Long Non-Coding RNAs in Ovarian Granulosa Cells from Women with PCOS with or Without Hyperandrogenism.

Association of Serum and Follicular Fluid Leptin Concentrations with Granulosa Cell Phosphorylated Signal Transducer and Activator of Transcription 3 Expression in Fertile Patients with Polycystic Ovarian Syndrome

[Effect of Follicle Stimulating Hormone on the Secretion of Anti-Mullerian Hormone in the Granulosa Cells in Patients with Polycystic Ovarian Syndrome].

Response of IGF and IL-6 to ovarian stimulation in PCOS and normal women

Subacute inflammatory reaction in follicular fluid of Chinese PCOS pa-tients

Autophagy of Ovarian Granulosa Cells in Polycystic Ovary Syndrome

The Release of Peripheral Immune Inflammatory Cytokines Promote an Inflammatory Cascade in PCOS Patients via Altering the Follicular Microenvironment

Expression of Leptin Mrna in Luteinized Granulosa Cells and Leptin Levels in Serum and Follicular Fluid of Non-Obese Infertile Patients with Polycystic Ovary Syndrome

[Effect of Luteinizing Hormone Vs Follicular Stimulating Hormone Ratio on Anti-Müllerian Hormone Secretion and Folliculogenesis in Patients with Polycystic Ovarian Syndrome].

The effect of estradiol on granulosa cell responses to FSH in women with polycystic ovary syndrome

Follicular Hyperandrogenism Downregulates Aromatase In Luteinized Granulosa Cells In Polycystic Ovary Syndrome Women

Progesterone levels on the hCG day and outcomes in vitro fertilization in women with polycystic ovary syndrome

Relationship between CCL25/CCR9 Levels in Follicular Fluid and High Ovarian Response in Patients with Polycystic Ovary Syndrome

LRH-1 high expression in the ovarian granulosa cells of PCOS patients